Discover and read the best of Twitter Threads about #Immunomedics
Most recents (2)
Why does chemotherapy kill cancerous but not normal cells? Most cancer biologists would answer this by stating that chemotherapy is selectively toxic to proliferating cells, and that cancer cell proliferate more than normal cells. Not exactly - there's a lot more to it.
Many normal tissues, like bone marrow and gut cells are actually more proliferative than even the most aggressive cancers. E.g. pro-myelocytes have a doubling time of around 17 hrs whilst even aggressive epithelial tumors double every 2-3 weeks or so.
So while many chemotherpeutics (e.g. #Temozolomide for GBM) show extensive myelotoxicity as a side effect, clinically useful ones are able to kill cancerous cells more efficaciously than normal ones, even if the latter proliferate faster, like pro-myelocytes.
How do they do it?
How do they do it?
Analysis: #NASDAQ $IMMU
Case 365 #Immunomedics Inc.
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
#IMMU 1/5
Case 365 #Immunomedics Inc.
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
#IMMU 1/5
Chart 1
Monthly Chart: The huge up move seen in Apr. 2020 saw price close above both the 20 year range top at 29.13 and Mar. 2020 trendline #resistance. A close above the 2013 #trendline is still in .....
IMMU 2/5
Monthly Chart: The huge up move seen in Apr. 2020 saw price close above both the 20 year range top at 29.13 and Mar. 2020 trendline #resistance. A close above the 2013 #trendline is still in .....
IMMU 2/5
..... process and a new all time high has just been recorded. The immediate target is 43.73 with the main objective at 53.84 and the long term synthetic resistance sloping at 63.75.
IMMU 3/5
IMMU 3/5
